Di Nuzzo Private Wealth, Inc. Immunity Bio, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $618 Million
- Q4 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 62 shares of IBRX stock, worth $196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62
Previous 17
264.71%
Holding current value
$196
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IBRX
# of Institutions
205Shares Held
70MCall Options Held
1.64MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$53.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$36.2 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$27.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$12.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$7.12 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.27B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...